Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ai-Ris Y Collier

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Vaccine|November 20, 2025
Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variantsNinaad Lasrado, Annika Rössler, Isabella McConnell, et al.
Plos One|March 27, 2026
Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoiresJasper Braun, Elliot D Hill, Elisa Contreras, et al.
Obstetrics and Gynecology|July 19, 2022
High-Dose Inhaled Nitric Oxide for the Treatment of Spontaneously Breathing Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19) PneumoniaCarlo Valsecchi, Dario Winterton, Bijan Safaee Fakhr, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, MassachusettsAi-Ris Y Collier, Catherine M Brown, Katherine Mcmahan, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Waning Immunity Against XBB.1.5 Following Bivalent mRNA BoostersNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
The Journal of Infectious Diseases|November 18, 2021
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed IndividualsAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.
Science Translational Medicine|March 8, 2022
Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variantAi-Ris Y Collier, Catherine M Brown, Katherine A McMahan, et al.
JCI Insight|September 10, 2021
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Alec A Schmaier, Gabriel M Pajares Hurtado, Zachary J Manickas-Hill, et al.
The New England Journal of Medicine|January 11, 2023
Immunogenicity of BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Immunogenicity of the BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|November 20, 2025
Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variantsNinaad Lasrado, Annika Rössler, Isabella McConnell, et al.
Plos One|March 27, 2026
Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoiresJasper Braun, Elliot D Hill, Elisa Contreras, et al.
Obstetrics and Gynecology|July 19, 2022
High-Dose Inhaled Nitric Oxide for the Treatment of Spontaneously Breathing Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19) PneumoniaCarlo Valsecchi, Dario Winterton, Bijan Safaee Fakhr, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, MassachusettsAi-Ris Y Collier, Catherine M Brown, Katherine Mcmahan, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Waning Immunity Against XBB.1.5 Following Bivalent mRNA BoostersNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
The Journal of Infectious Diseases|November 18, 2021
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed IndividualsAi-Ris Y Collier, Jingyou Yu, Katherine McMahan, et al.
Science Translational Medicine|March 8, 2022
Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variantAi-Ris Y Collier, Catherine M Brown, Katherine A McMahan, et al.
JCI Insight|September 10, 2021
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Alec A Schmaier, Gabriel M Pajares Hurtado, Zachary J Manickas-Hill, et al.
The New England Journal of Medicine|January 11, 2023
Immunogenicity of BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Immunogenicity of the BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Pageof 6